SCHEMBL30414734

SCHEMBL30414734

[2H]C([2H])([2H])N(C(=O)OC(C)(C)C)[C@@H](C)C(=O)N(C)OC

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.31
JAK3 P52333 1/20 0.30
BTK Q06187 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30414771 1.00 FAAH (0.31) FAAHJAK3BTK
SCHEMBL30414719 1.00 FAAH (0.31) FAAHJAK3BTK
SCHEMBL25745260 0.90 FAAH (0.33) FAAHJAK3BTK
SCHEMBL22965941 0.90 FAAH (0.33) FAAHJAK3BTK
SCHEMBL8647813 0.90 FAAH (0.33) FAAHJAK3BTK
SCHEMBL2264825 0.78 MEN1 (0.31)
SCHEMBL2264821 0.78 MEN1 (0.31)
SCHEMBL20061314 0.78 CA1 (0.33) FAAHJAK3BTK
SCHEMBL12201977 0.78 FAAH (0.32) FAAHJAK3BTK
SCHEMBL60274 0.78 FAAH (0.32) FAAHJAK3BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12234216-B2 Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof TERRAN BIOSCIENCES INC. (US) 2025-02-25 US disclosed
US-20240294488-A1 ISOTOPOLOGES, SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF TERRAN BIOSCIENCES INC (US) 2024-09-05 US disclosed
US-20230192642-A1 ISOTOPOLOGUES SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF TERRAN BIOSCIENCES INC. 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12234216-B2 Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof PYGB, NR3C2, CYP11B1 FAAH 2070/4885JAK3 2225/4885BTK 4741/4885
US-20230192642-A1 ISOTOPOLOGUES SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF PYGB, NR3C2, CYP11B1 FAAH 2070/4885JAK3 2225/4885BTK 4741/4885
US-20240294488-A1 ISOTOPOLOGES, SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF CYP11B1, PYGB, CYP11B2 FAAH 2125/4885JAK3 1614/4885BTK 4785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.